Search Results

This device is intended for medical purpose that is worn on the examination between patient and examiner. In addition, these examination gloves were tested for use with the following chemotherapy drug concentrations per ASTN D6978-05(2019):

The following drugs had NO breakthrough detected up to 240 minutes:
Cisplatin, 1.0 mg/ml (1,000 ppm)
Cyclophosphamide (Cytoxan),20.0 mg/ml (20,000 ppm)
Dacarbazine, 10.0 mg/ml (10,000 ppm)
Doxorubicin HCI, 2.0 mg/ml (2,000 ppm)
Etoposide, 20.0 mg/ml (20,000 ppm)
Fluorouracil, 50.0 mg/ml (50,000 ppm)
Paclitaxel, 6.0 mg/ml (6,000 ppm)

Please note that the following drugs have low permeation times of less than 240 minutes: Carmustine (BCNU) 3.3 mg/ml (3,300 ppm), 34.4minutes ThioTepa10.0 mg/ml (10,000 ppm),88.5 minutes

WARNING: Do not use with Carmustine and Thiotepa

Disposable Medical Nitrile Examination Gloves -Tested for Use with Chemotherapy Drugs

This document describes the FDA's clearance of "Disposable Medical Nitrile Examination Gloves - Tested for Use with Chemotherapy Drugs" (K220491). This is a medical device, specifically a non-powdered patient examination glove, and the information provided details its intended use and testing against chemotherapy drugs.

This section does not contain information about an AI/ML device or its performance criteria, study design, or ground truth establishment. The document is a clearance letter for a physical medical device (gloves) and focuses on their chemical resistance properties.

Therefore, I cannot provide the requested information about acceptance criteria, study details, sample sizes, expert qualifications, adjudication methods, MRMC studies, standalone performance, or ground truth for an AI/ML device based on this input.

Ask a specific question about this device

Ask a specific question about this device

This device is intended for medical purpose that is worn on the examiner's hand to prevent contamination between patient and examiner. In addition, these gloves were tested for use with the following chemotherapy drug concentrations per ASTM D6978-05(2019): The following drugs had NO breakthrough detected up to 240 minutes: Cisplatin, 1.0 mg/ml (1,000 ppm); Cyclophosphamide (Cytoxan), 20.0 mg/ml (20,000 ppm); Dacarbazine, 10.0 mg/ml (10,000 ppm); Doxorubicin HCI, 2.0 mg/ml (2,000 ppm); Etoposide, 20.0 mg/ml (20,000 ppm); Fluorouracil, 50.0 mg/ml (50,000 ppm); Paclitaxel, 6.0 mg/ml (6,000 ppm). Please note that the following drug has low permeation times of less than 60 minutes: Carmustine (BCNU) 3.3 mg/ml (3.300 ppm), 23.9minutes; ThioTepa10.0 mg/ml (10,000 ppm),25.3 minutes. WARNING: Do not use Carmustine and Thiotepa

Disposable Medical Nitrile Examination Gloves -Tested for Use with Chemotherapy Drugs

This document is a 510(k) premarket notification decision letter from the FDA for medical examination gloves. It does not contain any information about an AI/ML device or a study proving its performance. Therefore, I cannot provide the requested information about acceptance criteria and a study proving device performance in the context of an AI/ML medical device.

The document discusses:

• The clearance of "Disposable Medical Nitrile Examination Gloves - Tested for Use With Chemotherapy Drugs"
• The regulation number and product codes
• General controls provisions and other regulatory requirements for medical devices
• Indications for Use for the gloves, including specific chemotherapy drugs they were tested against and their breakthrough times.

There is no mention of acceptance criteria, study designs, sample sizes, expert involvement, ground truth, or any other elements related to the evaluation of an AI/ML-driven medical device.

Ask a specific question about this device